ART-IN-1(Cat No.:I043717)is a small molecule inhibitor designed to target and block the activity of the aryl hydrocarbon receptor (AhR), a protein involved in regulating immune responses, inflammation, and cancer progression. By inhibiting AhR, ART-IN-1 can modulate immune cell functions and reduce inflammation, making it a potential therapeutic for autoimmune diseases, chronic inflammation, and certain cancers. Preclinical studies have shown that ART-IN-1 can help improve the immune response and potentially enhance the effectiveness of cancer treatments, offering a novel approach for managing immune-related disorders.